Fleury S.A. (Brazil)
In research, Fleury S.A. (Brazil) stands highest in Medicine (#3,497 of 8,541 worldwide) and Health Sciences (#4,328 of 9,902 worldwide), 2022-now.
- World rank, 2022-now
- #12,915 of 22,385 · #13,985 all time
- Rank in Brazil
- #493 of 684
- Research works
- 701 ▲ 47% vs 2018-21
- Citations
- 7.9k 11.2 per fractional work
- Top-10% rate
- 7.1% all institutions 10.0%
- vs its own fields
- 0.93× 1.00× is exactly expected
- Open access
- 61% world 40%
- International
- 18% world 18%
What is Fleury S.A. (Brazil) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,497 of 8,541 | 7.9% | 157 | #3491 | |
| Health SciencesDomain | #4,328 of 9,902 | 7.8% | 164 | #4329 |
Each strip is that field's whole ranked pool, with the notch where Fleury S.A. (Brazil) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Fleury S.A. (Brazil) work in?
In 2022-now, 71% of research at Fleury S.A. (Brazil) is in Health Sciences, 18% in Life Sciences. Its largest fields are Medicine (68%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (4%). It does 3.0× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 26 fields, with their numbers
- Health Sciences18070.8%
- Medicine17368.1%
- Health Professions41.7%
- Dentistry10.5%
- Nursing10.3%
- Veterinary10.2%
- Life Sciences4517.9%
- Social Sciences176.8%
- Physical Sciences124.6%
- Engineering41.7%
- Computer Science41.5%
- Environmental Science20.7%
- Chemistry00.2%
- Physics and Astronomy00.2%
- Mathematics00.1%
- Materials Science00.1%
- Chemical Engineering00.0%
- Earth and Planetary Sciences00.0%
- Energy00.0%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.2×. Every wedge is a field page.
All 26 fields, with their numbers
- Immunology and Microbiology4.16×11 works
- Medicine3.54×173 works
- Biochemistry, Genetics and Molecular Biology2.14×29 works
- Veterinary1.66×1 works
- Dentistry0.99×1 works
- Economics, Econometrics and Finance0.78×4 works
- Nursing0.67×1 works
- Health Professions0.63×4 works
- Neuroscience0.60×2 works
- Pharmacology, Toxicology and Pharmaceutics0.37×0 works
- Social Sciences0.30×10 works
- Agricultural and Biological Sciences0.24×3 works
- Decision Sciences0.24×1 works
- Business, Management and Accounting0.22×2 works
- Computer Science0.19×4 works
- Environmental Science0.14×2 works
- Engineering0.12×4 works
- Chemistry0.11×0 works
- Mathematics0.11×0 works
- Arts and Humanities0.10×1 works
- Chemical Engineering0.09×0 works
- Physics and Astronomy0.08×0 works
- Psychology0.06×0 works
- Materials Science0.03×0 works
- Earth and Planetary Sciences0.01×0 works
- Energy0.01×0 works
- Immunology and Microbiology 4.2×
- Medicine 3.5×
- Biochemistry, Genetics and Molecular Biology 2.1×
- Veterinary 1.7×
- Dentistry 1.0×
- Economics, Econometrics and Finance 0.8×
- Nursing 0.7×
- Health Professions 0.6×
- Neuroscience 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Social Sciences 0.3×
- Agricultural and Biological Sciences 0.2×
- Decision Sciences 0.2×
- Business, Management and Accounting 0.2×
- Computer Science 0.2×
- Environmental Science 0.1×
- Engineering 0.1×
- Chemistry 0.1×
- Mathematics 0.1×
- Arts and Humanities 0.1×
- Chemical Engineering 0.1×
- Physics and Astronomy 0.1×
- Psychology 0.1×
- Materials Science 0.0×
- Earth and Planetary Sciences 0.0×
- Energy 0.0×
Who are the top researchers at Fleury S.A. (Brazil)?
Ranked on the quality score, Luciana Pardini Chamié, Maria Carolina Tostes Pintão and Miguel Mitne‐Neto lead among researchers whose main affiliation is Fleury S.A. (Brazil).
- 1
Luciana Pardini Chamié
Brazil · #433,792 worldwide 1.7k citations · 67 works
- 2
Maria Carolina Tostes Pintão
Brazil · #1,341,161 worldwide 2k citations · 33 works
- 3
Miguel Mitne‐Neto
Brazil · #1,387,677 worldwide 2.9k citations · 61 works
- 4
Karina Helena Morais Cardozo
Brazil · #1,652,035 worldwide 2.8k citations · 79 works
- 5
Isabela Azevedo Nicodemos da Cruz
Brazil · #1,855,319 worldwide 328 citations · 24 works
- 6
Adriana Lebkuchen
Brazil · #2,057,266 worldwide 375 citations · 16 works
- 7
Júlio Brandão Guimarães
Brazil · #2,212,759 worldwide 1k citations · 83 works
- 8
Wagner Antonio da Rosa Baratela
Brazil · #2,219,929 worldwide 803 citations · 46 works
- 9
Alípio Gomes Ormond Filho
Brazil · #2,386,000 worldwide 552 citations · 47 works
- 10
Valdemir Melechco Carvalho
Brazil · #2,391,810 worldwide 2.6k citations · 123 works
Which keywords describe research at Fleury S.A. (Brazil)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Prognostic Factors, Genetic Mutations, Rituximab, Diagnosis, Chemotherapy, Treatment and Hematopoietic Stem Cells.
- Molecular Profiling
- Cell-Free DNA
- Autoantibodies
- Minimal Residual Disease
- Viral Transmission
- PET Imaging
- Vaccine
- Cardiovascular Risk
- AML
- Precision Medicine
- Clinical Practice Guidelines
- Targeted Therapy
- Genomic Aberrations
- Therapeutic Targets
- Public Health
- Quality of Life
- Chemotherapy
- Inflammation
- Treatment
- Prognostic Factors
- Epidemiology
- Diagnosis
- Genetic Mutations
- Rituximab
- Immunotherapy
- Pathogenesis
- Hematopoietic Stem Cells
- Chronic Lymphocytic Leukemia
- Prognosis
- Breast Cancer
- Lymphoma
- Immune Response
- Acute Myeloid Leukemia
- Radiotherapy
- Mutation
- Pathophysiology
- Infection
- Vaccine Development
- Survival Analysis
- Prenatal Diagnosis
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology31▲ 3.1×79 topics
- Prognostic Factors18▲ 17×12 topics
- Diagnosis12▲ 4.9×30 topics
- Treatment11▲ 3.7×31 topics
- Genetic Mutations10▲ 9.5×18 topics
- Inflammation10▲ 1.95×36 topics
- Rituximab10▲ 28×4 topics
- Chemotherapy10▲ 5.4×19 topics
- Immunotherapy8▲ 4.4×18 topics
- Quality of Life8▲ 2.2×20 topics
- Pathogenesis7▲ 5.7×18 topics
- Public Health7▲ 1.92×19 topics
- Hematopoietic Stem Cells7▲ 32×3 topics
- Therapeutic Targets7▲ 18×2 topics
- Chronic Lymphocytic Leukemia7▲ 64×1 topic
- Genomic Aberrations7▲ 64×1 topic
- Prognosis6▲ 7.5×8 topics
- Targeted Therapy6▲ 11×5 topics
- Breast Cancer6▲ 9.7×10 topics
- Clinical Practice Guidelines6▲ 4.3×13 topics
- Lymphoma6▲ 14×4 topics
- Precision Medicine6▲ 4.6×6 topics
- Immune Response6▲ 4.0×16 topics
- AML6▲ 44×1 topic
- Acute Myeloid Leukemia6▲ 44×1 topic
- Cardiovascular Risk5▲ 5.7×8 topics
- Radiotherapy5▲ 4.6×10 topics
- Vaccine5▲ 4.5×9 topics
- Mutation4▲ 9.9×4 topics
- PET Imaging4▲ 10×4 topics
- Pathophysiology4▲ 6.0×7 topics
- Viral Transmission4▲ 13×4 topics
- Infection4▲ 6.7×5 topics
- Minimal Residual Disease4▲ 24×2 topics
- Vaccine Development4▲ 6.4×10 topics
- Autoantibodies4▲ 6.8×8 topics
- Survival Analysis4▲ 5.7×6 topics
- Cell-Free DNA4▲ 15×2 topics
- Prenatal Diagnosis3▲ 9.1×5 topics
- Molecular Profiling3▲ 14×3 topics
Which research topics does Fleury S.A. (Brazil) publish most on?
By volume in 2022-now: Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Lymphocytic Leukemia Research Genetics 7 works
- 2 Acute Myeloid Leukemia Research Hematology 6 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
- 4 Chronic Myeloid Leukemia Treatments Hematology 3 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 6 Cancer Genomics and Diagnostics Cancer Research 3 works
- 7 T-cell and Retrovirus Studies Immunology 2 works
- 8 Nutrition and Health in Aging Physiology 2 works
- 9 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
- 10 Multiple Myeloma Research and Treatments Hematology 2 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Fleury S.A. (Brazil)'s research output changed?
Output in 2022-2025 was 47% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Fleury S.A. (Brazil) as a percentage of every work published that year, 0.0011% in 2024.
Fractional works of Fleury S.A. (Brazil) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 9.4% in 2013.
Other research institutions in São Paulo
- Universidade de São Paulo
- Universidade Estadual Paulista (Unesp)
- Universidade Federal de São Paulo
- Pontifícia Universidade Católica de São Paulo
- Universidade Brasil
- Universidade Presbiteriana Mackenzie
- Universidade Nove de Julho
- Ação Educativa
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Fleury S.A. (Brazil). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
